)
Bouwinvest is pouring an additional $350M into North American CRE over the next two years, led by Bert van den Hoek in its New York office.
)
Five nine-figure deals closed before the new year, with firms in every asset class keeping their purchases quiet in 2020's closing days.
)
A confluence of factors, from shrinking lab equipment to digitization to outsourcing, is conspiring to shrink lab space, and change life sciences development.
)
Looming inflation will drive investors to flock to secure asset classes including life sciences and existing multifamily properties, experts said.
)
The East Bay is poised for a high growth trajectory over the next several years.
)
The huge demand for life sciences real estate, including labs and manufacturing, has brought life sciences construction firms a rush of new work.
)
Flush with cash, European life sciences markets now need to figure how to scale and skill up to match lab space demand.
)
An analysis of recent fundraising data finds these 11 biotech startups likely in the market for new real estate.
)
Boston’s King Street Properties made its first Bay Area purchase, making its life sciences real estate portfolio bicoastal.
)
These were the top deals in Boston during the last week.
We're not asking for your money. This is not a step towards a paywall. Our news is free and we intend to keep it that way.